Assessment of the feasibility of exon 45–55 multiexon skipping for duchenne muscular dystrophy

BACKGROUND: The specific skipping of an exon, induced by antisense oligonucleotides (AON) during splicing, has shown to be a promising therapeutic approach for Duchenne muscular dystrophy (DMD) patients. As different mutations require skipping of different exons, this approach is mutation dependent....

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: van Vliet, Laura, de Winter, Christa L, van Deutekom, Judith CT, van Ommen, Gert-Jan B, Aartsma-Rus, Annemieke
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2008
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2611974/
https://ncbi.nlm.nih.gov/pubmed/19046429
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2350-9-105
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia